Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Aspira Women's Health Inc AWH

Healthcare Medical Devices

Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Add To Watchlist

Recent & Breaking News (NDAQ:AWH)

Aspira Women's Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health®

GlobeNewswire May 12, 2021

Aspira Women's Health, Inc. Expands Leadership Team with Industry Veteran

GlobeNewswire May 11, 2021

Aspira Women's Health Inc. to Report First Quarter 2021 Financial Results on May 13

GlobeNewswire May 5, 2021

Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 25, 2021

Aspira Women's Health, Inc. Announces an Agreement for the Development and Commercialization of an Early-Detection Test for Identification of Ovarian Cancer

GlobeNewswire March 25, 2021

Aspira Women's Health Inc. to Report Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 18, 2021

Aspira Women's Health Inc. Announcement New York State Medicaid Now Considers OVA1® Medically Necessary as of April 1, 2021

GlobeNewswire March 15, 2021

Aspira Women's Health Inc. Appoints Nicole Sandford to its Board of Directors

GlobeNewswire February 22, 2021

Aspira Women's Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month

GlobeNewswire February 17, 2021

Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

GlobeNewswire February 12, 2021

Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX(TM) Clinical Report

GlobeNewswire February 10, 2021

Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock

GlobeNewswire February 4, 2021

Aspira Women's Health Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire February 3, 2021

Aspira Women's Health Inc. Announces it is Now a Highmark Contracted Provider in Pennsylvania and West Virginia

GlobeNewswire January 28, 2021

Aspira Women's Health, Inc. to Participate in Virtual Investor Events

GlobeNewswire January 4, 2021

Aspira Women's Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection Test

GlobeNewswire November 19, 2020

Aspira Women's Health Reports Third Quarter 2020 Financial Results

GlobeNewswire November 12, 2020

Aspira Women's Health, Inc. Strengthens Executive Leadership with New Appointments

GlobeNewswire November 10, 2020

Aspira Women's Health Strengthens Board of Directors with the Addition of Dr. Sandra E. Brooks

GlobeNewswire November 9, 2020

Aspira Women's Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

GlobeNewswire November 5, 2020